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Abstract
Background: During angiogenesis in the developing central nervous system (CNS),
endothelial cells (EC) detach from blood vessels growing on the brain surface, and
migrate into the expanding brain parenchyma. Brain angiogenesis is regulated by growth
factors and extracellular matrix (ECM) proteins secreted by cells of the developing
CNS. In addition, recent evidence suggests that EC play an important role in establishing
the neural stem cell (NSC) niche. Therefore, two-way communication between EC and
neural cells is of fundamental importance i n  t h e  d e v e l o p i n g  C N S .  T o  s t u d y  t h e
interactions between brain EC and neural cells of the developing CNS, a novel three-
dimensional (3-D) murine co-culture system was developed. Fluorescent-labelled brain
EC were seeded onto neurospheres; floating cellular aggregates that contain NSC/
neural precursor cells (NPC) and smaller numbers of differentiated cells. Using this
system, brain EC attachment, survival and migration into neurospheres was evaluated
and the role of integrins in mediating the early adhesive events addressed.
Results: Brain EC attached, survived and migrated deep into neurospheres over a 5-
day period. Neurospheres express the ECM proteins fibronectin and laminin, and brain
EC adhesion to neurospheres was inhibited by RGD peptides and antibodies specific for
the β1, but not the α6 integrin subunit.
Conclusion: A novel 3-D co-culture system for analysing the interactions between EC
and neural cells of the developing CNS is presented. This system could be used to
investigate the reciprocal influence of EC and NSC/NPC; to examine how NSC/NPC
influence cerebral angiogenesis, and conversely, to examine how EC regulate the
maintenance and differentiation of NSC/NPC. Using this system it is demonstrated that
EC attachment to neurospheres is mediated by the fibronectin receptor, α5β1 integrin.
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Background
During development the CNS is vascularized by angiogen-
esis, in which blood vessels covering the leptomeningeal
surface of the brain turn and grow in towards the CNS
parenchyma [1-3]. EC detach from the growing blood ves-
sels, to proliferate and migrate deeper into the cerebral
parenchyma. Evidence suggests that the patterns of cere-
bral angiogenesis are closely matched to the requirements
of the surrounding neural tissue. This is well illustrated in
the developing cerebral cortex in which emergence of the
different neuronal layers is closely followed by the appear-
ance of new blood vessels within each layer [2,4]. This
process proceeds in a timely and well-coordinated man-
ner. Studies show that cells of the developing CNS regu-
late angiogenesis by secretion of vascular endothelial
growth factor (VEGF) [5,6], and by production of
fibronectin along the pathway of migrating endothelial
cells [7]. More recently, it has been shown that NSC pro-
mote vascular tube formation in brain EC in vitro, by a
nitric oxide-mediated mechanism [8].
Conversely, recent studies have highlighted the role of
blood vessels in maintaining the stem cell niche within
the CNS [3,9]. Therefore, communication between EC
and neural cells of the developing CNS appears to be a
two-way street, with each cell type influencing the behav-
iour of the other. Consequently, a better understanding of
the molecular signals that mediate these interactions may
be important not only for angiogenesis, but also for the
maintenance and differentiation of NSC/NPC within the
CNS.
Many factors have been implicated in angiogenesis,
including the growth factors VEGF and bFGF, the ephrins,
the angiopoietins [10-12], and molecules of the ECM,
such as fibronectin and laminin [13,14]. Interestingly,
many of these factors also influence NSC/NPC behaviour
[15], raising the notion that NSC/NPC and EC are both
regulated by an evolutionary-conserved set of molecular
signals, that help to co-ordinate the establishment and
maintenance of the developing CNS.
The ECM provides signals that promote EC survival, pro-
liferation, migration and differentiation [16-20]. The
major class of ECM receptors are the integrins, which are
expressed at the cell surface as noncovalently linked αβ
heterodimers [21-24]. Within the CNS, β1 integrins are
expressed at high levels by EC [25-28], and their expres-
sion is tightly regulated in different pathological states
including stroke, multiple sclerosis and neoplasia [26,29-
32]. An important role for β1 integrins in cerebral angio-
genesis was suggested by the recent study from this labo-
ratory describing β1 integrin expression during postnatal
CNS development [27]. This revealed that brain EC
showed a developmental switch in their expression of β1
integrins, from predominantly fibronectin receptors
(α4β1 and α5β1 integrins) in the early stages of angiogen-
esis to laminin receptors (α1β1 and α6β1 integrins) in the
adult stable state. This suggests that the switch from
fibronectin to laminin signalling might be an important
factor regulating EC behaviour, switching the cells from
an angiogenic phenotype into a more stable differentiated
state.
In order to test this idea we recently examined the influ-
ence of different ECM proteins on brain EC behaviour in
vitro. This showed that fibronectin was the most effective
protein at promoting EC survival and proliferation, and
that this effect was mediated via the α5β1 and αvβ3
integrins by a MAP kinase-dependent signalling pathway
[33]. This study, like many others, was performed on sim-
ple two-dimensional (2-D) substrates. In light of the
increasing realization that cells within 3-D systems show
different modes of behaviour than those in 2-D [34,35],
the aim of the current study was to develop a 3-D system
to examine interactions between EC and cells of the devel-
oping CNS. Fluorescent-labelled brain EC were seeded
onto neurospheres, free-floating spheres of cells contain-
ing predominantly NSC, NPC and smaller numbers of dif-
ferentiated cells. This system models the outside-in EC
invasion into the brain that occurs during development
[1-3]. In this system, the potential role of β1 integrins in
mediating EC attachment and migration into neuro-
spheres has been examined.
Results
Brain EC attach to neurospheres
The aim of this study was to develop a 3-D system to
examine interactions between EC and cells of the develop-
ing CNS. The neurosphere system was utilized, in which
postnatal neural cells are cultured under non-adherent
conditions in the presence of the growth factors EGF and
FGF2. In these cultures, NSC proliferate to form free-float-
ing neurospheres, containing predominantly NSC, NPC
and smaller numbers of differentiated cells of neuronal or
glial lineage [36-38]. As an initial step in this study, pri-
mary cultures of mouse brain EC were seeded onto the
surface of mouse neurospheres to determine whether EC
would attach and migrate into neurospheres, as a means
of recapitulating the EC ouside-in invasion of the CNS
parenchyma that occurs during development.
First, mouse neurospheres were plated in a small volume
(25 µl) of neurosphere media in the centre of wells within
a 24-well plate. Each drop contained between 20–25 neu-
rospheres of size range 80–200 µm. Neurospheres were
used for the first 4 passages and then discarded. After leav-
ing the neurospheres 15 minutes to settle down on the
plastic base, a 10 µl single cell suspension containing
20,000 cell-tracker-labelled mouse brain EC was sus-BMC Neuroscience 2007, 8:3 http://www.biomedcentral.com/1471-2202/8/3
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pended over the neurospheres. The small volumes were
designed to maximise interactions between EC and neuro-
spheres. After 2 hours incubation, 0.5 ml of neurosphere
media was gently added to the well, and the plates
returned to the incubator. EC adhesion to neurospheres
was examined after 18 hours co-culture, by observing the
living cultures under fluorescent microscopy. As shown in
Figure 1 (panels A and B), after 18 hours incubation, it
appeared that most neurospheres were covered in fluores-
cent-labelled EC. To assess the proportion of EC that had
attached to neurospheres, the number of attached EC was
first counted using fluorescent microscopy. However, this
proved very difficult because of the 3-D nature of the cul-
ture system and the mobile nature of free-rolling neuro-
spheres. Therefore EC attachment to neurospheres was
assessed in an alternative approach by quantifying the
number EC that did not attach to neurospheres. This was
achieved by first, removing all neurospheres and EC from
the non-adherent plates into a centrifuge tube and allow-
ing the neurospheres to separate out by gravity. Next, the
number of EC in the remaining supernatant was counted
using a haemocytometer. This showed that of the 20,000
EC added to the neurosphere cultures, 63.2 ± 14.3% had
not attached to a neurosphere (n = 6 experiments). In an
additional approach the number of fluorescent-labelled
EC that attached to neurospheres was also quantified by
flow cytometry. In this approach, the sedimented neuro-
spheres containing attached EC were dissociated with
trypsin into a single cell suspension before analysis by
flow cytometry to quantify the absolute number of fluo-
rescent-labelled EC present within the cell population.
This showed that of the original 20,000 EC plated onto
the neurospheres 30.8 ± 5.6% (n = 3 experiments) had
attached to a neurosphere. These results are largely con-
sistent and show that approximately one-third of the orig-
inally-plated EC attach to the neurospheres under the
conditions in this assay system.
The co-cultures were maintained for a further 5 days to
assess whether the attached EC would survive for longer
periods. This was important to establish because the EC-
neurosphere co-cultures were maintained in serum-free
media, so as to prevent NSC/NPC adhesion and differen-
tiation, and EC do not normally survive in serum-free
conditions [39,40]. However, as illustrated in Figure 1
(panels C and D), after 5 days culture, many EC still
remained attached to neurospheres, showing that in this
system, EC do survive in the absence of serum. This sug-
gests that EC in contact with neurospheres obtain suffi-
cient pro-survival signals, most likely as a result of their
strong adhesion to neurospheres, and from pro-survival
factors released from the NSC/NPC within the neuro-
spheres.
Brain EC migrate into neurospheres
Having established that EC can attach to neurospheres
and survive for periods of up to 5 days, the next aim was
to determine whether EC actively migrated into neuro-
spheres, or just remained superficially attached to the neu-
rosphere surface. To examine this, fresh frozen sections of
5 day-old EC-neurosphere co-cultures were analysed for
the distribution of fluorescent-labelled EC within the neu-
rospheres. As shown in Figure 2, many fluorescent-
labelled EC were detected within neurospheres, and these
cells were distributed not just at the edge of the neuro-
spheres, but throughout the entire neurosphere structure.
To examine how effectively EC migrate into neurospheres,
the number of EC within neurospheres was determined
by counting the number of fluoresecent-labelled EC in 10
different 10 µm sections of the EC-neurosphere co-cul-
tures, each containing between 10–15 neurospheres. As
shown in Figure 2E, this showed that the majority of neu-
rospheres contained EC, though approximately 25% of
neurospheres contained no EC. The observation that
some neurospheres contained absolutely no EC, even at
the neurosphere surface, supports the idea that EC failed
to contact these neurospheres in the original plating pro-
cedure. To gain some idea of the survival rate of EC within
this co-culture system, a calculation was performed based
Brain EC attachment to neurospheres Figure 1
Brain EC attachment to neurospheres. Mouse brain EC were 
prepared, labelled with the fluorescent cell tracker marker 
(green), plated onto mouse neurospheres, and then cultured 
under serum-free conditions, as described in Methods. After 
18 hours (A and B) and 5 days (C and D), EC adhesion to 
neurospheres was examined by fluorescent microscopy. 
Representative cultures are shown by phase (A and C) and 
fluorescent (B and D) images. Scale bars = 100 µm. Note that 
after 18 hours co-culture many fluorescent-labelled EC had 
attached to neurospheres and that after 5 days, many EC 
were still present, and were concentrated on or within neu-
rospheres.BMC Neuroscience 2007, 8:3 http://www.biomedcentral.com/1471-2202/8/3
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on the cell counts of EC within co-culture sections. In light
of the observation that within this system the average neu-
rosphere diameter was 150 µm, it was estimated that by
counting EC in 15 sections of 10 µm each, this would
include all EC present. Using this calculation, it was deter-
mined that over the course of three separate experiments,
that of the 20,000 EC originally co-cultured with neuro-
spheres, 20.55 ± 7.8% EC survived up to day 5 of the
experiment. In light of the observation that neurospheres
are capable of fusing in culture [41], it is possible that the
appearance of EC within neurospheres could be explained
by neurosphere fusion and incorporation of the surface-
attached EC into the centre of aggregated neurospheres.
To exclude the possibility that this might be the reason for
detecting EC within neurospheres, single neurospheres
were plated into the centre of wells within 24-well tissue
culture plates and then seeded with fluorescent-labelled
EC. Subsequent analysis of frozen sections by fluorescent
microscopy revealed that fluorescent-labelled EC were
detected throughout the neurospheres plated as single
neurospheres, confirming that EC migrate readily through
neurospheres.
When the morphology of the fluorescent-labelled EC
inside neurospheres was examined (Figure 3), it was
noticed that EC were often grouped together in small
aggregates, and in a small number of cases, the EC had
formed linear groups of cells, reminiscent of those
observed during the early stages of vascular development
in the CNS [3,27]. These linear groups of EC were never
found in the early stages of EC-neurosphere co-culture,
and only became apparent after 5 days culture. Because
some studies have reported that NSC within neurospheres
can differentiate into EC [42], next, expression of the
endothelial-specific marker CD31 (PECAM-1) was exam-
ined by immunofluorescence. This showed that cells
within neurospheres not containing any fluoresecent-
labelled EC did not express CD31. However in neuro-
spheres receiving EC, CD31-positive cells were distributed
throughout the neurospheres, and in some cases the
CD31-positive cells showed a linear vascular-like appear-
ance (Figure 4). Furthermore, CD31-positive cells nega-
tive for the fluorescent cell-tracker label were never
detected, suggesting that NSC/NPC within the neuro-
sphere did not differentiate into EC.
Neurospheres express the ECM proteins fibronectin and 
laminin
A previous report from this laboratory demonstrated that
brain EC express integrin receptors for fibronectin and
laminin [33]. To address whether these two ECM proteins
are expressed within neurospheres, immunohistochemis-
try was performed on frozen neurospheres, using polyclo-
nal antibodies specific for fibronectin and laminin. This
showed that both ECM ligands were expressed within
neurospheres (Figure 5). Fibronectin was expressed
throughout neurospheres, with a pattern that outlined
individual cell bodies of the neurosphere. Laminin was
expressed in an intricate fibrillar pattern, outlining cell
processes between cells. Interestingly, while fibronectin
expression was distributed throughout the neurosphere
structure, laminin expression was highest on cells within
the core of neurospheres.
Integrins promote EC attachment to neurospheres
This study has demonstrated that primary mouse brain EC
attach, migrate and survive within mouse neurospheres,
thus validating this system as a tool to investigate the
molecular mechanisms mediating interactions between
EC and NSC/NPC within the developing CNS. The spe-
cific focus of this research group is to understand the role
of integrins in regulating EC behaviour within the CNS.
Brain EC migration into neurospheres Figure 2
Brain EC migration into neurospheres. Mouse brain EC were 
prepared, labelled with cell tracker, and then plated onto 
mouse neurospheres, as described in Methods. 5 days later, 
the distribution of fluorescent-labelled EC within neuro-
spheres was examined by fluorescent microscopy of frozen 
sections of EC-neurosphere co-cultures, using Hoechst 
(blue) to identify all cell nuclei (A and C) and the FITC chan-
nel (green) to identify the cell tracker-labelled EC (B and D). 
Scale bar = 100 µm. Panel E shows a histogram of the distri-
bution of EC number within neurospheres in a representa-
tive experiment (n = 3). Note that EC were detected in the 
majority of neurospheres.BMC Neuroscience 2007, 8:3 http://www.biomedcentral.com/1471-2202/8/3
Page 5 of 11
(page number not for citation purposes)
Previously our studies demonstrated a developmental
switch in EC integrins, from fibronectin-mediated signal-
ling during the early stages of angiogenesis, to laminin-
mediated signalling during endothelial differentiation
[27]. To extend this work, the next set of studies were
designed to test the hypothesis that β1 integrins provide
important instructional cues that drive the early events of
angiogenesis in the CNS, such as EC adhesion and migra-
tion into the developing CNS.
To investigate the importance of integrins in mediating
adhesive interactions between EC and neurospheres, the
impact of integrin function-blocking reagents on EC
attachment to neurospheres was evaluated. Fluorescent-
labelled EC were added to cultures of neurospheres in the
presence of the different function-blocking reagents: con-
trol DGR peptide, blocking peptide RGD (which targets
the α5β1 integrin but not α6β1), isotype control anti-
body, anti-β1 integrin antibody (Ha2/5), or the anti-α6
integrin antibody, GoH3. As before, 10 µl containing
20,000 fluoresecent-labelled EC was suspended over a 25
µl drop containing 20–25 neurospheres of size range 80–
200 µm. After 18 hours culture the effect of integrin block-
ade on EC adhesion to neurospheres was quantified, by
first, measuring the proportion of EC that remained unat-
tached to NS and second, by flow cytometry of the neuro-
sphere population to quantify the number of
fluoresecent-labelled EC that had attached to neuro-
spheres. As shown in Figure 6, when compared to control
conditions, EC attachment to neurospheres was signifi-
cantly inhibited both by the RGD peptides (reduced to
15.4 ± 3.5% of the control value, p < 0.01) and by the pan-
β1 integrin antibody (reduced to 23.4 ± 3.3% of the con-
trol value, p < 0.01), but not by the control DGR peptides,
isotype-control antibody or by the anti-α6 antibody. Flow
cytometric analysis yielded very similar results (not
shown). Taken together, these results suggest that EC
attachment to neurospheres is dependent on the fibronec-
tin-binding α5β1 integrin but not the laminin-binding
α6β1 integrin.
Discussion
In this study a novel 3-D co-culture system to study the
interactions between brain EC and neural cells of the
developing CNS is presented. Using neurospheres as a
model of the developing CNS, brain EC were seeded onto
neurospheres in an attempt to mimic the outside-in EC
invasion into the CNS that occurs during development [1-
3]. The studies demonstrate that EC attach, migrate and
survive inside neurospheres. In addition, to investigate
the potential role of integrins in promoting the early
stages of cerebral angiogenesis, the studies revealed that
neurospheres express fibronectin and laminin, the appro-
priate ECM ligands for EC β1 integrins, and that EC
attachment to neurospheres is mediated by the α5β1
integrin.
Angiogenesis has become intensely studied because of its
involvement in many pathological processes, particularly
neoplasia [12,43,44]. In the CNS, angiogenesis is an
important part of normal development [1,2,4], but it also
occurs in a number of pathological conditions in the adult
CNS, including arteriovenous malformations (AVMs)
[45,46], neoplastic conditions [47-51], and cerebral
The morphology of brain EC in neurospheres after 5 days Figure 3
The morphology of brain EC in neurospheres after 5 days. Mouse brain EC were prepared, labelled with cell tracker, and 
plated onto mouse neurospheres, as described in Methods. 5 days later, brain EC morphology was analysed in frozen sections 
under fluorescent microscopy. A-C are representative examples of the morphologies observed. Scale bar = 50 µm. Note that 
after 5 days co-culture, some brain EC form linear structures within neurospheres, reminiscent of the early vascular structures 
observed in the developing CNS.BMC Neuroscience 2007, 8:3 http://www.biomedcentral.com/1471-2202/8/3
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Expression of fibronectin and laminin within neurospheres Figure 5
Expression of fibronectin and laminin within neurospheres. 
Frozen sections of mouse neurospheres were prepared as 
described in Methods and expression of fibronectin and lam-
inin examined by immunofluorsecent microscopy. Neuro-
spheres were labelled with normal rabbit serum (B), or 
primary antibodies against fibronectin (D) or laminin (F), 
before labelling with a Cy-3 conjugated secondary anti-rabbit 
antibody. All cell nuclei of the neurospheres were identified 
by Hoechst labelling (A, C, E). Scale bar = 100 µm. Note that 
fibronectin was expressed throughout the neurosphere, with 
a pattern that outlined individual cell bodies, while laminin 
labelled cell processes between cells, and was expressed pre-
dominantly by cells nearer the centre of the neurosphere.
CD31 immunofluorescence of EC-neurosphere co-cultures  after 5 days culture Figure 4
CD31 immunofluorescence of EC-neurosphere co-cultures 
after 5 days culture. Mouse brain EC were plated onto 
mouse neurospheres, as described in Methods. Five days 
later, CD31 immunohistochemistry was performed on fro-
zen sections using Hoechst to label all cell nuclei (A) and 
CD31 (Cy-3 conjugated secondary antibody, (B) to identify 
EC. Merged channels (C). Scale bar = 50 µm. Note that after 
5 days co-culture, CD31-positive structures were observed 
that resembled early vascular structures.BMC Neuroscience 2007, 8:3 http://www.biomedcentral.com/1471-2202/8/3
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ischaemia [52-54]. Therefore an improved understanding
of the molecular events that underlie brain angiogenesis is
of high priority. The growing realization that cells behave
differently in 2-D versus 3-D environments [34,35,55] has
led many to believe that it may be more informative to
study EC behaviour in 3-D rather than 2-D systems. To
address this, many studies have used matrigel, fibrin or
collagen 3-D gels to try and create a more complex 3-D
environment [55-59]. However the drawback of these
approaches is that while they are 3-D, they may be too
simplistic, containing only one or two ECM proteins, and
do not contain other cell types that may be important for
orchestrating angiogenesis during development. The
novel 3-D co-culture system described in this study may
be a significant step forward for several reasons. First, the
neurosphere system provides a simple 3-D model of the
developing CNS, containing the major cell types present
within the developing CNS at the time of angiogenesis,
including NSC, NPC and other more differentiated cells
[36-38]. Second, unlike culture systems that use postnatal
astrocytes [60-62], the majority of neural cells within the
neurosphere are at an immature stage of development,
thus closely mimicking the environmental cues that
migrating EC will encounter as they start to invade the
developing CNS [36-38]. Third, unlike the complexity of
the developing in vivo situation, the EC-neurosphere co-
culture model is relatively easy to establish, and is amena-
ble to manipulation and analysis.
This 3-D system could be used to address several different
fundamental questions relating to interactions between
EC and NSC/NPC. First, it could be used to investigate the
influence of EC on NSC/NPC maintenance, proliferation
and differentiation. In light of the notion that blood ves-
sels may be an important component of the stem cell
niche [9], and the findings by Temple et al [3], that EC
promote NSC proliferation and induce NSC differentia-
tion along the neuronal pathway, it will be interesting to
investigate this influence in the 3-D system presented
here. Second, it could be used to investigate the influence
of NSC/NPC on EC behaviour and thus angiogenesis. Pre-
vious data shows that neurons, astrocytes and NSC pro-
duce soluble factors that promote angiogenesis [5,6,8].
The system presented here would be a valuable tool for
characterising NSC/NPC factors involved in this regula-
tion. Third, it provides a good system to examine the role
of specific candidate molecules in regulating the different
stages of brain angiogenesis. In the work presented here,
it is demonstrated that the fibronectin-α5β1 integrin
interaction is important for the initial EC adhesion to neu-
rospheres. In future studies this avenue will be extended
by using EC derived from integrin null mice and siRNA to
examine the role of individual integrins and key compo-
nents of the integrin-associated intracellular signalling
pathways. In this initial study it was noted that while EC
attach and migrate into the body of neurospheres, the
actual degree of vascular tube formation after 5 days co-
culture under baseline conditions was relatively small. In
future work, the ability of well-described angiogenic fac-
tors such as bFGF [12,63] or TGF-β1 [64,65] to promote
vascular tube formation will be evaluated in this system.
This 3-D system was used to explore the role of ECM-
integrin interactions in regulating some of the early events
mediating brain angiogenesis. Importantly, it was found
that EC attached rapidly and migrated into the centre of
neurospheres. Previously we have shown that in the devel-
oping CNS, EC switch from a predominantly fibronectin
signalling pathway (high expression of α4 and α5
integrins and surrounded by fibronectin) to a laminin sig-
nalling pathways (high expression of α1 and α6 integrins
and surrounded by laminin) [27]. In keeping with the
observations of others [66] the work presented here con-
firms that both fibronectin and laminin are expressed by
neural cells within the neurosphere, thus providing the
ECM ligands for EC integrins to interact with. Interest-
ingly, while fibronectin was expressed throughout the
neurospheres, laminin expression was focussed preferen-
Analysis of the roles of specific integrins in mediating brain  EC attachment to neurospheres Figure 6
Analysis of the roles of specific integrins in mediating brain 
EC attachment to neurospheres. Cell-tracker-labelled mouse 
brain EC were plated onto mouse neurospheres, in the pres-
ence of the different integrin function-blocking reagents: 
RGD peptides, the β1 integrin monoclonal antibody Ha2/5, 
or the α6 integrin monoclonal antibody GoH3. Control 
DGR peptides, or an isotype-matched monoclonal antibody 
were included for controls. 18 hours later, EC adhesion to 
neurospheres was quantified. Adhesion is expressed as the 
percentage of EC adhesion to neurospheres under control 
conditions (no reagents added); all points represent the 
mean ± SD of four experiments. * indicates statistically signif-
icant effect (p < 0.01). Note that EC adhesion to neuro-
spheres was inhibited by RGD peptides and the β1 integrin 
monoclonal antibody, but not by the α6 integrin antibody.BMC Neuroscience 2007, 8:3 http://www.biomedcentral.com/1471-2202/8/3
Page 8 of 11
(page number not for citation purposes)
tially at the centre of neurospheres. In addition, function-
blocking studies showed that the α5β1 integrin, a
fibronectin receptor, is important in promoting EC attach-
ment to neurospheres. This is consistent with the observa-
tion that EC migrating from the brain surface into the
parenchyma during development are in close contact with
a fibronectin-rich matrix [1], and also from our previous
work showing that fibronectin-mediated interactions are
dominant in the early stages of cerebral angiogenesis [27].
Taken together, these findings suggest that fibronectin-
mediated events play an important role in the early stages
of EC adhesion and migration in the developing CNS.
Conclusion
A novel 3-D system for investigating interactions between
EC and NSC/NPC is presented. When plated onto neuro-
spheres, brain EC attached, survived and migrated into
neurospheres. This system could be used to investigate the
reciprocal influence of EC and NSC/NPC; to examine how
NSC/NPC influence cerebral angiogenesis, and con-
versely, to examine how EC regulate the maintenance and
differentiation of NSC/NPC. Here, this system has been
used to show that EC attachment to neurospheres is medi-
ated by the fibronectin receptor, α5β1 integrin.
Methods
Cell culture
All cell cultures were maintained in a humidified incuba-
tor at 37°C and 5% CO2. Primary cultures of mouse brain
EC were prepared as previously described [33] according
to the method of Sapatino [67], with some modifications.
Briefly, brains of adult C57BL6 mice (2–3 months old)
were removed, cleaned of meninges and external blood
vessels, then finely chopped, and dissociated for one hour
in an enzymatic solution containing 30 U/ml papain
(Worthington Biochemicals, Lorne Laboratories, United
Kingdom), 0.24 mg/ml L-cysteine (Sigma) and 40 µg/ml
DNAse I type IV (Sigma) in 1 ml MEM-HEPES, as previ-
ously described for mixed glial cultures [68]. After incuba-
tion, the disrupted brain tissue was triturated 10 times
with a 10 ml syringe, first through a 19-gauge needle, then
through a 21-gauge needle. The brain tissue was then
added to a universal 25 ml tube containing 22% bovine
serum albumin (BSA), and centrifuged at 1000 g for 10
minutes, in order to separate out the myelin that is
retarded at the top of the tube, from the vascular tubes and
other cells at the bottom of the tube. This process was
repeated 2 times, each time re-centrifuging the myelin
fraction to harvest more cells and tubes. Finally, the col-
lected vascular tubes and cells were resuspended and fil-
tered through a 40 µm cell strainer (Falcon, Oxford,
United Kingdom) to separate the vascular tubes from sin-
gle cells. The tubes were then washed and centrifuged in
MEM-HEPES before being resuspended in endothelial cell
growth media (ECGM) consisting of Hams F12, supple-
mented with 10% FCS, Heparin, ascorbic acid, L-
glutamine (all from Sigma) and endothelial cell growth
supplement (ECGS) (First Link, Birmingham, United
Kingdom). T25 tissue culture flasks (Falcon) had previ-
ously been coated for 2 hours with collagen type I
(Sigma), which was then cross-linked in a box containing
ammonia vapour for 30 minutes before being rinsed 2
times with PBS and left in the incubator for 1 hour to
equilibrate. The brain EC were then added to the collagen-
coated flasks and left to grow at 37°C and 5% CO2. The
EC purity of the cultures was assessed by live immunos-
taining with antibodies for the EC surface markers CD31
(PECAM-1) and CD105 (endoglin), and determined as
greater than 95% pure EC. In these experiments EC were
used only for the first two passages and then discarded.
Primary cultures of neurospheres were obtained from
postnatal (P0–P2) C57BL6 mouse brains as described pre-
viously [69]. Briefly, spheres of neural precursors were
grown in uncoated Iwaki non-adherent T25 tissue culture
flasks (Bibby Sterilin, Stone, United Kingdom) in DMEM/
Hams F12 (Sigma, Poole, United Kingdom) (50:50) sup-
plemented with 1% B27 (Life Technologies, Paisley,
United Kingdom), 20 µg/ml epidermal growth factor
(EGF, Calbiochem, Nottingham, United Kingdom) and
20  µg/ml fibroblast growth factor-2 (FGF2, Peprotech,
London, United Kingdom). Cells were plated at an initial
plating density of two brains per T25 flask. After 3 days the
contents of each T25 flask were centrifuged at 800 rpm for
3 minutes and the neurosphere pellet resuspended
through a 1 ml pipette and plated into four fresh T25
flasks. Neurospheres were subsequently passaged every 5–
7 days into fresh flasks and fresh media.
Antibodies and peptides
The following antibodies used in immunocytochemistry,
immunohistochemistry and function-blocking studies
were obtained from: (1) Pharmingen (La Jolla, CA): mon-
oclonal antibodies against CD31 (PECAM-1, clone
MEC13.3), CD105 (endoglin, clone MJ7/18), α6 integrin
(clone GoH3), β1 integrin (clone Ha2/5), (2) Sigma: rab-
bit polyclonal antibodies against fibronectin and laminin.
The FITC and Cy-3-conjugated secondary antibodies were
obtained from DAKO (Ely, United Kingdom). The
GRGDS (function-blocking) and SDGRG (control-inac-
tive) peptides were obtained from Sigma.
Immunocytochemistry
For assessment of EC purity, cells were cultured on colla-
gen I or fibronectin (both from Sigma) coated glass cover-
slips in ECGM. Cells were blocked in 5% normal goat
serum (NGS) in PBS for 30 minutes before being live-
labelled with monoclonal antibodies specific for CD31 or
CD105 for 1 hour at room temperature. Cells were then
washed in PBS and incubated with secondary FITC-conju-BMC Neuroscience 2007, 8:3 http://www.biomedcentral.com/1471-2202/8/3
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gated secondary antibodies for 1 hour at room tempera-
ture and washed again. The cells were then fixed in acid/
alcohol (95:5) at -20°C for 30 minutes, before being
extensively washed and incubated with Hoechst stain
(Sigma) for 10 minutes at room temperature to label all
cell nuclei. Coverslips were then washed again before
being mounted in aquamount (Polysciences, Warrington,
PA). Fresh frozen 10 µm sections of neurospheres and
neurospheres seeded with EC were prepared by rapid
freezing of neurospheres in OCT, and cryostat sections
prepared at -20°C. The sections were dried and then fixed
briefly in acetone/methanol (50:50) for 60 seconds before
being rinsed extensively in PBS and blocked for 30 min-
utes at room temperature in 5% NGS in PBS. Sections
were then immunostained with primary antibodies
against fibronectin or laminin (1:100 dilution) for 1 hour
at room temperature, washed for 10 minutes in PBS, incu-
bated for 1 hour with secondary antibodies (1:200 dilu-
tion), washed for 10 minutes, and then cell nuclei labelled
with the Hoechst stain for 10 minutes. Finally sections
were washed in PBS and mounted in aquamount.
Analysis of endothelial cell interactions with neurospheres
Mouse neurospheres were plated in a small volume (25
µl) of neurosphere media in the centre of wells within a
24-well plate. Each drop contained between 20–25 neuro-
spheres of size range 80–200 µm. Neurospheres were used
for the first 4 passages and then discarded. After leaving
the neurospheres 15 minutes to settle down on the plastic
base, a 10 µl single cell suspension containing approxi-
mately 20,000 cell-tracker-labelled brain EC was sus-
pended over the neurospheres. The small volumes were
designed to maximise interactions between EC and neuro-
spheres. After 2 hours incubation, 0.5 ml of neurosphere
media was gently added to the well, and the plates
returned to the incubator. Primary cultures of mouse
brain EC were labelled with cell tracker (Molecular
Probes, Eugene, OR, USA) according to the manufacturers
instructions. Briefly, ECGM was removed and EC incu-
bated with 1:1000 dilution of cell tracker in serum free
Hams F12 media for 45 minutes. The labelling media was
then removed and EC incubated in ECGM for a further 1
hour before being trypsinised off the dish. Trypsin (Life
Technologies) was blocked with DMEM containing 10%
FCS and the EC pelleted at 1200 rpm. Labelled EC were
resuspended in neurosphere growth media at a cell den-
sity of 2 × 106 EC/ml, and 10 µl volumes of this cell sus-
pension added gently on top of the previously prepared
neurospheres. The cultures were then left to incubate for 2
hours before adding another 0.5 ml neurosphere media to
each well and the cultures returned to the incubator.
These cultures were left undisturbed for 18 hours and then
examined under the fluorescent microscope for evidence
of fluorescent-labelled EC attachment to neurospheres.
EC attachment to neurospheres was quantified by the
reverse approach of counting the number of EC that did
not attach to neurospheres. Briefly, neurospheres and EC
were removed from the non-adherent plates into a centri-
fuge tube and left for 2 minutes to allow the neurospheres
to settle down by gravity. The residual supernatant con-
taining unattached EC was centrifuged at 1500 rpm to pel-
let the EC, and then the number of EC measured using a
haemocytometer. EC attachment to neurospheres was
also quantified by flow cytometry of trypsin-dissociated
EC-neurosphere co-cultures. Neurospheres were allowed
to settle by gravity for 2 minutes and then dissociated in
0.05% trypsin-EDTA (Sigma) for 5 minutes at 37°C. The
number of fluoresecent-labelled EC within the co-culture
was then quantified by flow cytometry of the mixed cell
population and calculated as a percentage of the number
of EC initially plated. In the function-blocking experi-
ments, the blocking reagents were added to the EC for 15
minutes before plating on neurospheres, and then main-
tained for the duration of the experiment. GRGDS (RGD)
and SDGRG (DGR) peptides were included at 0.1 mg/ml,
and the β1 (Ha2/5) and α6 (GoH3) integrin antibodies
included at 10 µg/ml. Each condition was repeated in
duplicate in each experiment. The results are expressed as
the mean ± SD of four experiments. Statistical significance
was assessed by using the Student's paired t test in which
P < 0.05 was defined as statistically significant.
For the analysis of EC incorporation into neurospheres,
frozen sections of EC-neurosphere co-cultures were dried
and then fixed briefly in acetone/methanol (50:50) for 60
seconds before being rinsed in PBS and mounted in aqua-
mount. To determine the proportion of neurospheres that
contain EC, the number of fluorescent-labelled EC within
neurospheres was measured in 10 different 10 µm sec-
tions of the EC-neurosphere co-cultures, each section con-
taining between 10–15 neurospheres. To calculate the
approximate survival rate of EC within this co-culture sys-
tem, we performed a calculation based on our cell counts
of EC within the co-culture sections. As the average neuro-
sphere diameter is 150 µm, we reasoned that by counting
the EC in 15 sections of 10 µm each, this would include
all EC present. The number of fluorescent-labelled EC
within neurospheres was counted within 3 separate sec-
tions, and this number multiplied by a factor of 5 to give
an estimate of the total number of EC present within the
co-culture.
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